Combined chemotherapy and surgery in primary small cell carcinoma of the esophagus

Minerva Chirurgica

Volumn 70, Issue 2, 2015, Pages 69-75

  Li, J ^a   Li, D ^a   Xu, M ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Carcinoma, small cell; Esophagus; Surgical procedures, operative; Survival

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; CANCER STAGING; CARCINOMA, SMALL CELL; ESOPHAGEAL NEOPLASMS; ESOPHAGUS RESECTION; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PROCEDURES; RETROSPECTIVE STUDY; SURVIVAL; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84946403959     PISSN: 00264733     EISSN: 18271626     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Deepak P, Devi R, Pillai H. Esophageal small cell carcinoma with synchronous renal cell carcinoma: a case report with review of the literature. Case Rep Gastroenterol 2011;5:196-200.
2. Madroszyk A, Egreteau J, Martin L, Queneau PE, Bosset JF, Merrouche Y. Small-cell carcinoma of the esophagus: report of three cases and review of the literature with emphasis on therapy. Ann Oncol 2001;12:1321-5.
3. Hosokawa A, Shimada Y, Matsumura Y, Yamada Y, Muro K, Hamaguchi T et al. Small cell carcinoma of the esophagus. Analysis of 14 cases and literature review. Hepatogastroenterology 2005;52:1738-41.
4. Wu Z, Ma JY, Yang JJ, Zhao YF, Zhang SF. Primary small cell carcinoma of esophagus: report of 9 cases and review of literature. World J Gastroenterol 2004;10:3680-2.
5. Chen SB, Yang JS, Yang WP, Weng HR, Li H, Liu DT et al. Treatment and prognosis of limited disease primary small cell carcinoma of esophagus. Dis Esophagus 2011;24:114-9.
6. Lü JM, Liang J, Wang JW, He J, Xiao ZF, Zhang HX et al. Clinical analysis of 126 patients with primary small cell carcinoma of the esophagus. Zhonghua Zhong Liu Za Zhi 2009;31:121-5.
7. Medgyesy CD, Wolff RA, Putnam JB Jr, Ajani JA. Small cell carcinoma of the esophagus: the University of Texas M. D. Anderson Cancer Center experience and literature review. Cancer 2000;88:262-7.
8. Nevárez A, Saftoiu A, Bhutani MS. Primary small cell carcinoma of the esophagus: clinico-pathological features and therapeutic options. Curr Health Sci J 2011;37:31-4.
9. Al Mansoor S, Ziske C, Schmidt-Wolf IG. Primary small cell carcinoma of the esophagus: patient data metaanalysis and review of the literature. Ger Med Sci 2013;11:Doc12.
10. Sobin LH, Gospodarowicz MK, Wittekind Ch. Oesophagus including oesophagogastric junction. TNM classification of malignant tumours. Seventh Edition. New York: Wiley-Blachwell; 2009.
11. Haider K, Shahid RK, Finch D, Sami A, Ahmad I, Yadav S et al. Extrapulmonary small cell cancer: a Canadian province's experience. Cancer 2006;107:2262-9.
12. Cheedella NK, Suzuki A, Xiao L, Hofstetter WL, Maru DM, Taketa T et al. Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort. Ann Oncol 2013;24:1262-6.
13. Brenner B, Shah MA, Gonen M, Klimstra DS, Shia J, Kelsen DP. Small-cell carcinoma of the gastrointestinal tracta retrospective study of 64 cases. Br J Cancer 2004;90:1720-6.
14. Zhang BH, Yang WJ, Zhao L, He J, Wang YG, Zhang HT. Surgical treatment and prognostic analysis of 109 patients with primary esophageal small cell carcinoma. Zhonghua Zhong Liu Za Zhi 2012;34:698-702.
15. Nöda K, Nishiwaki Y, Kawahara M, Negoro S, Sugiura T, Yokoyama A et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung Cancer. N Engl J Med 2002;346:85-91.
16. Knox JJ, Wong R, Visbal AL, Horgan AM, Guindi M, Hornby J et al. Phase 2 trial of preoperative irinotecan plus cisplatin and conformai radiotherapy, followed by surgery for esophageal cancer. Cancer 2010;116:4023-32.